Varex Imaging Corp (VREX) - Net Assets
Based on the latest financial reports, Varex Imaging Corp (VREX) has net assets worth $490.80 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.10 Billion) and total liabilities ($607.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Varex Imaging Corp's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $490.80 Million |
| % of Total Assets | 44.7% |
| Annual Growth Rate | 2.8% |
| 5-Year Change | -1.99% |
| 10-Year Change | -9.27% |
| Growth Volatility | 15.38 |
Varex Imaging Corp - Net Assets Trend (2014–2025)
This chart illustrates how Varex Imaging Corp's net assets have evolved over time, based on quarterly financial data. Also explore how large is Varex Imaging Corp's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Varex Imaging Corp (2014–2025)
The table below shows the annual net assets of Varex Imaging Corp from 2014 to 2025. For live valuation and market cap data, see VREX market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $486.60 Million | -11.40% |
| 2024-09-30 | $549.20 Million | -5.47% |
| 2023-09-30 | $581.00 Million | +6.27% |
| 2022-09-30 | $546.70 Million | +10.11% |
| 2021-09-30 | $496.50 Million | +6.59% |
| 2020-09-30 | $465.80 Million | +1.30% |
| 2019-09-30 | $459.80 Million | +4.64% |
| 2018-09-30 | $439.40 Million | +12.61% |
| 2017-09-30 | $390.20 Million | -27.24% |
| 2016-09-30 | $536.30 Million | +8.21% |
| 2015-09-30 | $495.60 Million | +37.93% |
| 2014-09-30 | $359.30 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Varex Imaging Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 590000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $400.00K | 0.08% |
| Other Comprehensive Income | $-5.20 Million | -1.10% |
| Other Components | $483.30 Million | 102.26% |
| Total Equity | $472.60 Million | 100.00% |
Varex Imaging Corp Competitors by Market Cap
The table below lists competitors of Varex Imaging Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Longxing Chemical Stock Co Ltd
SHE:002442
|
$459.56 Million |
|
Eupraxia Pharmaceuticals Inc. Common Stock
NASDAQ:EPRX
|
$459.64 Million |
|
Hyundai Motor Securities Co. Ltd.
KO:001500
|
$459.68 Million |
|
Servcorp Ltd
AU:SRV
|
$459.77 Million |
|
ProCredit Holding AG & Co KGaA
XETRA:PCZ
|
$459.41 Million |
|
Unipar Carbocloro S.A
SA:UNIP3
|
$459.36 Million |
|
Zhejiang XinNong Chemical Co Ltd Class A
SHE:002942
|
$459.33 Million |
|
Shanghai Fudan Forward S&T Co Ltd
SHG:600624
|
$459.27 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Varex Imaging Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 535,100,000 to 472,600,000, a change of -62,500,000 (-11.7%).
- Net loss of 70,300,000 reduced equity.
- Other comprehensive income decreased equity by 2,300,000.
- Other factors increased equity by 10,100,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-70.30 Million | -14.88% |
| Other Comprehensive Income | $-2.30 Million | -0.49% |
| Other Changes | $10.10 Million | +2.14% |
| Total Change | $- | -11.68% |
Book Value vs Market Value Analysis
This analysis compares Varex Imaging Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.02x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.24x to 1.02x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-09-30 | $9.36 | $11.61 | x |
| 2015-09-30 | $12.62 | $11.61 | x |
| 2016-09-30 | $13.70 | $11.61 | x |
| 2017-09-30 | $9.97 | $11.61 | x |
| 2018-09-30 | $11.10 | $11.61 | x |
| 2019-09-30 | $11.55 | $11.61 | x |
| 2020-09-30 | $11.64 | $11.61 | x |
| 2021-09-30 | $11.99 | $11.61 | x |
| 2022-09-30 | $12.82 | $11.61 | x |
| 2023-09-30 | $11.29 | $11.61 | x |
| 2024-09-30 | $13.12 | $11.61 | x |
| 2025-09-30 | $11.42 | $11.61 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Varex Imaging Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -14.88%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.32%
- • Asset Turnover: 0.76x
- • Equity Multiplier: 2.34x
- Recent ROE (-14.88%) is below the historical average (5.41%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 30.64% | 16.07% | 1.58x | 1.21x | $74.17 Million |
| 2015 | 16.51% | 12.65% | 1.08x | 1.20x | $31.54 Million |
| 2016 | 13.02% | 11.05% | 1.00x | 1.18x | $15.90 Million |
| 2017 | 13.61% | 7.39% | 0.67x | 2.74x | $13.70 Million |
| 2018 | 6.45% | 3.56% | 0.78x | 2.32x | $-15.12 Million |
| 2019 | 3.48% | 1.99% | 0.75x | 2.33x | $-29.10 Million |
| 2020 | -12.82% | -7.84% | 0.65x | 2.52x | $-103.07 Million |
| 2021 | 3.60% | 2.13% | 0.71x | 2.37x | $-30.93 Million |
| 2022 | 5.68% | 3.53% | 0.73x | 2.22x | $-23.04 Million |
| 2023 | 8.49% | 5.40% | 0.71x | 2.20x | $-8.57 Million |
| 2024 | -8.91% | -5.88% | 0.67x | 2.27x | $-101.21 Million |
| 2025 | -14.88% | -8.32% | 0.76x | 2.34x | $-117.56 Million |
Industry Comparison
This section compares Varex Imaging Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,555,245,291
- Average return on equity (ROE) among peers: -57.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Varex Imaging Corp (VREX) | $490.80 Million | 30.64% | 1.24x | $459.44 Million |
| Abbott Laboratories (ABT) | $24.08 Billion | 18.37% | 0.83x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $1.47 Billion | -46.29% | 2.07x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $15.99 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.10 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $30.20 Million | 15.56% | 0.78x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $22.89 Million | 2.69% | 0.23x | $125.55 Million |
About Varex Imaging Corp
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction … Read more